Poland· PL-100045376
Tinctura Hyperici Herbpol w Krakowie SA
A hyperici herba product containing hyperici herbae tinctura, registered in Poland by Krakowskie Zakłady Zielarskie "Herbapol" w Krakowie S.A.. The same ATC class is registered in 7 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Hyperici herba is registered in 7 of 19 countries.
Countries holding a registration under ATC N06AX25 (hyperici herba), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Hyperici herba · ATC N06AX25
7 / 19 countries
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Hyperici herbae tinctura
- Manufacturer
- Krakowskie Zakłady Zielarskie "Herbapol" w Krakowie S.A.
- Country
- Poland (PL)
- ATC code
- N06AX25
- ATC class
- Hyperici herba
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990074617
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
293 interactions on record for hyperici herba.
Graded by severity as the source publishes them — 141 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Hyperici herba · interactions on record
293 records
- 141 severe
- 144 moderate
- 8 minor
Most severe, free to view
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- PalonosetronA04AA05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N06AX25
Hyperici herba, as other registers publish it.
- NetherlandsA.Vogel Hyperiforce, tablettenA.Vogel B.V.
- SwitzerlandDeprivita
- SwitzerlandDeprivita
- SwitzerlandDeprivita, FilmtablettenPermamed AG
- SwitzerlandEssenssia 250 mg, comprimés pelliculésLabatec Pharma SA
- SwitzerlandEssenssia 500 mg, comprimés pelliculésLabatec Pharma SA
- FinlandHyperiforce NovaA. Vogel Oy
- SwitzerlandHyperiforce, TablettenA.Vogel AG
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/286d090f-3a33-4e43-9cec-a17b547cf2a2 GET /v1/drugs/286d090f-3a33-4e43-9cec-a17b547cf2a2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Płyn doustny",
"source": "urpl",
"strength": "-",
"packaging": "05909990074617 ¦ OTC ¦ 6781\n1 op. 100 ml",
"substance": "Hyperici tinctura 100 g/100 g",
"common_name": "Hyperici herbae tinctura",
"pl_product_id": "100045376",
"pozwolenie_nr": "00746",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about hyperici herba.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.